Egypt’s Almouneer gets $3.6M to scale its platform for treating diabetes and obesity

We are very excited to be announcing this round - an important achievement and milestone in our journey. Over the past year, we managed to grow our team and successfully built DRU. This round will now catapult us into the next phase of our business, helping us grow our team and talent further, invest in our technology and broaden DRU's provider network - inching us even closer to our vision. And as we do, we'd like to extend our deepest gratitude to our investors - Noor Sweid and Said Murad from Global Ventures, Henry Engelhardt of Wrightwood Investments, and Proparco - for their belief in us and in our mission. We also wouldn't be here today had it not been for the unwavering support and championing of Cartier Women's Initiative, INSEAD, Endeavor and from our friends at Alliance Law Firm.

We are thrilled to welcome Almouneer to the Global Ventures portfolio, and lead the company's seed round. Over the years, we have had the privilege of working with a stellar group of healthcare entrepreneurs who are materially improving the lives of patients worldwide, enhancing access, quality and cost of care. Noha and Rania are now part of this group. We are excited to work alongside them as they leverage their specialized expertise across business-building and chronic care to tackle a prevalent health issue across the Middle East and Africa. On its mission to become the lifelong companion of diabetic patients in the region, Almouneer is a unique and necessary innovation.

The work Almouneer does is truly valuable to the ever-growing diabetic community in Egypt and beyond. Noha Khater and Rania Kadry, its two leaders, are truly exceptional, talented people, driven to make a positive difference to so many people's lives. Wrightwood Investments [the family office of Diane & Henry Engelhardt] is proud to be an investor and part of the Almouneer family.

Almouneer is dedicated to fostering innovation and industry disruption through its array of digital services for patients and clinic networks. This objective strongly aligns with the goals of both Proparco and Digital Africa.

Digital Africa welcomes Almouneer to the Bridge Fund portfolio with great enthusiasm, as we are investing in a strategic, high-impact sector. We are delighted to contribute to Noha and her teams, and behind them all the patients for who Almouneer simplifies life.